Pharmacogenetics: focus on pharmacodynamics
作者： Klaus Lindpaintner , Elizabeth Foot , Mark Caulfield , Ian Hall
DOI: 10.1097/00124363-200104000-00009
关键词:
摘要:
springer.com
sci-hub.se 参考文章(23)
M Magierowska, L Meyer, C Rouzioux, C Katlama, I Theodorou, HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group. The Lancet. ,vol. 349, pp. 1219- 1220 ,(1997)
Jeffrey M. Drazen, Chandri N. Yandava, Louise Dubé, Natalie Szczerback, Richard Hippensteel, Antonino Pillari, Elliot Israel, Nicholas Schork, Eric S. Silverman, David A. Katz, Jeffrey Drajesk, Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment Nature Genetics. ,vol. 22, pp. 168- 170 ,(1999) , 10.1038/9680
William A. Haseltine, Not quite pharmacogenomics Nature Biotechnology. ,vol. 16, pp. 1295- 1295 ,(1998) , 10.1038/4244
K H In, K Asano, D Beier, J Grobholz, P W Finn, E K Silverman, E S Silverman, T Collins, A R Fischer, T P Keith, K Serino, S W Kim, G T De Sanctis, C Yandava, A Pillari, P Rubin, J Kemp, E Israel, W Busse, D Ledford, J J Murray, A Segal, D Tinkleman, J M Drazen, Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. Journal of Clinical Investigation. ,vol. 99, pp. 1130- 1137 ,(1997) , 10.1172/JCI119241
C. M. Drysdale, D. W. McGraw, C. B. Stack, J. C. Stephens, R. S. Judson, K. Nandabalan, K. Arnold, G. Ruano, S. B. Liggett, Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 10483- 10488 ,(2000) , 10.1073/PNAS.97.19.10483
Yaoxing Huang, William A. Paxton, Steven M. Wolinsky, Avidan U. Neumann, Linqi Zhang, Tian He, Stanley Kang, Daniel Ceradini, Zhanqun Jin, Karina Yazdanbakhsh, Kevin Kunstman, Daniel Erickson, Elizabeth Dragon, Nathaniel R. Landau, John Phair, David D. Ho, Richard A. Koup, The role of a mutant CCR5 allele in HIV–1 transmission and disease progression Nature Medicine. ,vol. 2, pp. 1240- 1243 ,(1996) , 10.1038/NM1196-1240
D W McGraw, S L Forbes, L A Kramer, S B Liggett, Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression. Journal of Clinical Investigation. ,vol. 102, pp. 1927- 1932 ,(1998) , 10.1172/JCI4862
T Hutchin, G Cortopassi, Proposed molecular and cellular mechanism for aminoglycoside ototoxicity. Antimicrobial Agents and Chemotherapy. ,vol. 38, pp. 2517- 2520 ,(1994) , 10.1128/AAC.38.11.2517
M. Dean, M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, S. J. O'Brien, , Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene Science. ,vol. 273, pp. 1856- 1862 ,(1996) , 10.1126/SCIENCE.273.5283.1856
F D Martinez, P E Graves, M Baldini, S Solomon, R Erickson, Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. Journal of Clinical Investigation. ,vol. 100, pp. 3184- 3188 ,(1997) , 10.1172/JCI119874